Used to detect and quantify BAP (Bromodomain-associated protein) activity in mouse samples, this ELISA kit is essential in research settings focused on epigenetic regulation. It enables researchers to measure changes in BAP levels in response to drug treatments, genetic modifications, or disease states such as cancer, inflammation, and neurological disorders. The kit is widely used in preclinical studies to evaluate the effectiveness of bromodomain inhibitors and other epigenetic therapies. Its high sensitivity and specificity make it suitable for analyzing tissue extracts, cell lysates, and biological fluids. This tool supports drug development and mechanistic studies in molecular biology and immunology.